Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 2011, 875249

Calcium and Vitamin D Supplementation in Men


Calcium and Vitamin D Supplementation in Men

Evelien Gielen et al. J Osteoporos.


Calcium and vitamin D supplements reverse secondary hyperparathyroidism and are widely prescribed to prevent osteoporotic fractures, with proven antifracture efficacy when targeted to individuals with documented insufficiencies. Men who should particularly be considered for calcium and vitamin D supplements include elderly or institutionalized individuals, patients with documented osteoporosis on antiresorptive or anabolic medication, and individuals receiving glucocorticoids. Benefits are most apparent when a daily dose of 1000-1200 mg calcium is complemented with 800 IU vitamin D. Compliance is the key to optimizing clinical efficacy. While (conventionally dosed) vitamin D has not been associated with safety concerns, recent meta-analytic data have provided evidence to suggest that calcium supplements (without coadministered vitamin D) may potentially be associated with cardiovascular risks.

Similar articles

See all similar articles

Cited by 6 PubMed Central articles

See all "Cited by" articles


    1. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC, USA: National Osteoporosis Foundation; 2008.
    1. Heaney RP. Is the paradigm shifting? Bone. 2003;33(4):457–465. - PubMed
    1. Boonen S, Bischoff-Ferrari HA, Cooper C, et al. Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcified Tissue International. 2006;78(5):257–270. - PubMed
    1. Boonen S, Vanderschueren D, Geusens P, Bouillon R. Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men. International Journal of Andrology. 1997;20(3):134–143. - PubMed
    1. Visser M, Deeg DJH, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (Sarcopenia): the longitudinal aging study Amsterdam. Journal of Clinical Endocrinology and Metabolism. 2003;88(12):5766–5772. - PubMed

LinkOut - more resources